Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostate Adenocarcinoma × apalutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 33 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castrate-sensitive Prostate Cancer 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

bicalutamide 2 Radiotherapy 2 Radiation 2 relugolix 1 niraparib 1 luprolide acetate gel depot 1 histrelin 1 enzalutamide 1 darolutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Triptorelin Pamoate 1 Specimen Handling 1 Salicylic Acid 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Leuprolide 1 Goserelin 1 Flutamide 1 Buserelin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡